MedPath

Docetax Injection Concentrate 20 mg

Registration Number: MAL12050005AZ

Approved
Approval ID

e1d30b3f06898631

Registration Number

MAL12050005AZ

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

0.5ml mLAvailable
Package Size: 0.5ml mL
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

DOCETAXEL TRIHYDRATEActive
Monograph: docetaxel trihydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Docetax Injection Concentrate 20 mg - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform